RNA Q2 2020 Earnings — Avidity Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

RNAAvidity Biosciences, Inc.

$2B

Q2 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M+587.9% YoY

Gross Profit

$2M100.0% margin

Operating Income

-$10M-672.8% margin

Net Income

-$11M-685.0% margin

EPS (Diluted)

$-1.23

QoQ Revenue Growth

+13.5%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$8M

Stock-Based Comp.

$687,000

Balance Sheet

Total Assets

$355M

Total Liabilities

$25M

Stockholders' Equity

$330M

Cash & Equivalents

$352M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$224,000	+587.9%
Gross Profit	$2M	-$2M	+166.7%
Operating Income	-$10M	-$4M	-165.5%
Net Income	-$11M	-$5M	-106.3%